Stocks and Investing Stocks and Investing
Thu, June 30, 2022
Wed, June 29, 2022
Tue, June 28, 2022

Roy Buchanan Maintained (ABUS) at Buy with Decreased Target to $9 on, Jun 28th, 2022


Published on 2024-10-27 21:39:45 - WOPRAI, Roy Buchanan
  Print publication without navigation


Roy Buchanan of JMP Securities, Maintained "Arbutus Biopharma Corporation" (ABUS) at Buy with Decreased Target from $10 to $9 on, Jun 28th, 2022.

Roy has made no other calls on ABUS in the last 4 months.



There are 2 other peers that have a rating on ABUS. Out of the 2 peers that are also analyzing ABUS, 0 agree with Roy's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Roy


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $8.5 on, Monday, March 14th, 2022
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $6 on, Friday, March 4th, 2022